Home > News > Recent cases

Recent cases

Manitowoc Beverage Systems Limited and Malachy Scott Sr et al BL O/019/1415 January 2014Ashton Chantrielle recently appeared for the patentee in a patent revocation action at the Intellectual Property Office. The patent related to a system for cooling and dispensing beverage in which the beverage was cooled en route to the dispensing font. The font was also cooled to create a decorative ice effect. The claimant applied to […]
Starsight Telecast Inc (Rovi) v Virgin Media Ltd [2014] EWHC 8 (pat)9 January 2014Members of Chambers recently appeared for both sides in a partial summary judgment application in the on-going series of litigation between Rovi and Virgin Media. James Abrahams appeared for Rovi defending the application made by Virgin, who were represented by James Whyte. In October 2012 the EPO Opposition Division held the claims of one of […]
Actavis Group v Sanofi (C-443/12)12 December 2013Four members of chambers recently appeared in a hearing at the CJEU in the much anticipated preliminary reference hearing regarding the availability of Supplementary Protection Certificates (“SPC”). Richard Meade QCand Isabel Jamal appeared for Actavis. Daniel Alexander QC represented Sanofi and Charlotte May was instructed by the United Kingdom Government as an interested party. Sanofi’s […]
HTC Corp v Nokia Corp [2013] EWHC 324712 December 2013Michael Tappin QC  recently appeared with Nicholas Saunders and Miles Copeland for Nokia, the successful patentee in a revocation and infringement action. Nokia’s patent was for a modulator structure using a Gilbert cell in mobile telecommunications. HTC claimed that the patent was invalid for reasons of lack of novelty and for obviousness over two prior […]
Microsoft Corp v Motorola Mobility LLC [2013] EWCA Civ 161311 December 2013Richard Meade QCand James Abrahams recently appeared for Microsoft, the successful respondents to an appeal brought by Motorola, represented by Daniel Alexander QC and Tim Powell. Motorola’s appeal was from the judgment of Arnold J [2012] EWHC 3677 (pat) revoking its European patent relating to the status synchronisation of multiple mobile devices, and dismissing its […]
Hospira UK Ltd v Novartis AG [2013] EWCA Civ 166311 December 2013Michael Tappin QC  recently appeared with Tom Mitcheson for Hospira and Generics, the successful respondents to an appeal brought by Novartis against the invalidation of one of its patents. Novartis’ patent related to the use of a particular member of the bisphosphonate class of drugs, zoledronate. Claim 7 claimed the use of zoledronate for the […]
IPC Media Ltd v Media 10 [2013]EWHC 3796 (IPEC)6 December 2013James Mellor QC and Jessie Bowhill recently acted for the successful defendant in IPC Media Ltd v Media 10. The claimant was the owner of the well known IDEAL HOME magazine and the defendant ran the IDEAL HOME SHOW. The parties (or their predecessors) had co-existed in the market for almost 100 years. The claimant […]
Taylor v Maguire [2013] EWHC 3804 (IPEC)3 December 2013Ashton Chantrielle recently appeared for the Claimant artist in a copyright infringement case in the IP Enterprise Court. The Claimant was a paper artist running an online business making and selling paper cuttings. It was alleged that the Defendant had infringed copyright in those works by creating, replicating, possessing and dealing in works, which replicated […]
Actavis UK Ltd. & Ors v Eli Lilly & Co [2013] EWHC 3749 (Pat)30 November 2013Isabel Jamal recently appeared with Thomas Raphael for Actavis UK Ltd., the successful respondent to an application by Eli Lilly (“Lilly”) for stays on the basis of alleged abuse of process, against certain actions initiated by Actavis for declarations of non-infringement of the Lilly’s patents. The dispute between the parties relates to four actions in […]
Teva Pharma BV v Amgen Inc [2013] EWHC 3711 (pat)21 November 2013James Abrahams recently appeared for Teva Pharma BV and Teva UK Ltd (“Teva”) resisting an application that the First Defendant (“AI”) cease to be a party to the proceedings issued by Teva. Proceedings had initially been issued against AI alone as the registered proprietor of the European patent in issue. AI had however assigned the […]